Marine Natural Products as Leads against SARS-CoV-2 Infection

Area of Science:

• Marine natural products chemistry
• Virology
• Drug discovery

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, highlights the urgent need for diverse antiviral therapies.
• Current interventions are insufficient, with a lack of drugs featuring varied molecular structures and mechanisms.

Purpose of the Study:

• To investigate the antiviral potential of marine natural products against SARS-CoV-2.
• To identify novel compounds that can inhibit viral replication without causing toxicity to host cells.

Main Methods:

• Screening of three marine natural products: homofascaplysin A, (+)-aureol, and bromophycolide A.
• Evaluation of antiviral activity through inhibition of SARS-CoV-2 replication.
• Assessment of compound toxicity in human airway epithelial cells.

Main Results:

• Homofascaplysin A, (+)-aureol, and bromophycolide A demonstrated significant inhibition of SARS-CoV-2 replication.
• These compounds were found to be non-toxic to human airway epithelial cells at effective concentrations.

Conclusions:

• The studied marine natural products exhibit potent antiviral activity against SARS-CoV-2.
• These compounds represent promising leads for the development of new anti-SARS-CoV-2 drugs.